ID   HAS_PASMD               Reviewed;         972 AA.
AC   Q7BLV3; O68389; O85457;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 2.
DT   07-JAN-2015, entry version 52.
DE   RecName: Full=Hyaluronan synthase;
DE            EC=2.4.1.212;
DE   Includes:
DE     RecName: Full=Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-beta-N-acetylglucosaminyltransferase;
DE     AltName: Full=UDP-GlcNAc transferase;
DE   Includes:
DE     RecName: Full=N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase;
DE              EC=2.4.1.226;
DE     AltName: Full=UDP-GlcUA transferase;
GN   Name=hyaD;
OS   Pasteurella multocida.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pasteurellales;
OC   Pasteurellaceae; Pasteurella.
OX   NCBI_TaxID=747;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Serogroup A:1 / X73;
RX   PubMed=9770287; DOI=10.1111/j.1574-6968.1998.tb13903.x;
RA   Chung J.Y., Zhang Y., Adler B.;
RT   "The capsule biosynthetic locus of Pasteurella multocida A:1.";
RL   FEMS Microbiol. Lett. 166:289-296(1998).
RN   [2]
RP   SEQUENCE REVISION TO 855-972.
RA   Chung J.Y., Zhang Y., Adler B.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 15742 / P1059;
RX   PubMed=9525958; DOI=10.1074/jbc.273.14.8454;
RA   DeAngelis P.L., Jing W., Drake R.R., Achyuthan A.M.;
RT   "Identification and molecular cloning of a unique hyaluronan synthase
RT   from Pasteurella multocida.";
RL   J. Biol. Chem. 273:8454-8458(1998).
RN   [4]
RP   SEQUENCE REVISION TO 43.
RA   DeAngelis P.L., Jing W., Achyuthan A.M.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10873488; DOI=10.1006/mpat.2000.0365;
RA   Fuller T.E., Kennedy M.J., Lowery D.E.;
RT   "Identification of Pasteurella multocida virulence genes in a
RT   septicemic mouse model using signature-tagged mutagenesis.";
RL   Microb. Pathog. 29:25-38(2000).
RN   [6]
RP   CHARACTERIZATION, AND MUTAGENESIS OF ASP-196 AND ASP-477.
RC   STRAIN=ATCC 15742 / P1059;
RX   PubMed=10988250; DOI=10.1093/glycob/10.9.883;
RA   Jing W., DeAngelis P.L.;
RT   "Dissection of the two transferase activities of the Pasteurella
RT   multocida hyaluronan synthase: two active sites exist in one
RT   polypeptide.";
RL   Glycobiology 10:883-889(2000).
RN   [7]
RP   CHARACTERIZATION, AND MUTAGENESIS OF ASP-247; ASP-249; GLU-369;
RP   ASP-370; ASP-527; ASP-529 AND ASP-563.
RX   PubMed=12799342; DOI=10.1093/glycob/cwg085;
RA   Jing W., DeAngelis P.L.;
RT   "Analysis of the two active sites of the hyaluronan synthase and the
RT   chondroitin synthase of Pasteurella multocida.";
RL   Glycobiology 13:661-671(2003).
CC   -!- FUNCTION: Catalyzes the polymerization of hyaluronan, a
CC       polysaccharide composed of a repeating disaccharide of N-
CC       acetylglucosamine (GlcNAc) and glucuronic acid (GlcUA) units. Each
CC       unit has the composition in beta-(1->4)-GlcUA-beta-(1->3)-GlcNAc.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-N-acetyl-D-glucosamine + beta-D-
CC       glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-(nascent
CC       hyaluronan) = UDP + N-acetyl-beta-D-glucosaminyl-(1->4)-beta-D-
CC       glucuronosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-(nascent
CC       hyaluronan).
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-beta-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-(nascent
CC       hyaluronan) = UDP + beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-
CC       glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-(nascent
CC       hyaluronan).
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + N-acetyl-beta-D-
CC       galactosaminyl-(1->4)-beta-D-glucuronosyl-proteoglycan = UDP +
CC       beta-D-glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-
CC       beta-D-glucuronosyl-proteoglycan.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=160 uM for UDP-N-acetyl-D-glucosamine;
CC         KM=140 uM for UDP-D-glucuronate;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. CS/HAS
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF067175; AAC67250.2; -; Genomic_DNA.
DR   EMBL; AF036004; AAC38318.2; -; Genomic_DNA.
DR   EMBL; AF237926; AAF68412.1; -; Genomic_DNA.
DR   PIR; T09595; T09595.
DR   ProteinModelPortal; Q7BLV3; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   SABIO-RK; Q7BLV3; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0050501; F:hyaluronan synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC.
DR   Gene3D; 3.90.550.10; -; 2.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF00535; Glycos_transf_2; 2.
DR   SUPFAM; SSF53448; SSF53448; 3.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycosyltransferase; Membrane; Multifunctional enzyme;
KW   Repeat; Transferase.
FT   CHAIN         1    972       Hyaluronan synthase.
FT                                /FTId=PRO_0000059259.
FT   REGION      152    325       A1.
FT   REGION      432    604       A2.
FT   MUTAGEN     196    196       D->E,K,N: Complete loss of GlcNAc
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:10988250}.
FT   MUTAGEN     247    247       D->E,K,N: Complete loss of GlcNAc
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     249    249       D->E,K,N: Complete loss of GlcNAc
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     369    369       E->D: Complete loss of GlcNAc transferase
FT                                activity. Regains 30% of wild-type
FT                                activity at high UDP-GlcNAc
FT                                concentrations.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     369    369       E->H,Q: Complete loss of GlcNAc
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     370    370       D->E,K,N: Complete loss of GlcNAc
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     477    477       D->E,K,N: Complete loss of GlcUA
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:10988250}.
FT   MUTAGEN     527    527       D->E,K,N: Complete loss of GlcUA
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     529    529       D->E: 90% loss of GlcUA transferase
FT                                activity. {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     529    529       D->K,N: Complete loss of GlcUA
FT                                transferase activity.
FT                                {ECO:0000269|PubMed:12799342}.
FT   MUTAGEN     563    563       D->E,K,N: No effect.
FT                                {ECO:0000269|PubMed:12799342}.
FT   CONFLICT     17     17       Q -> E (in Ref. 1; AAC67250).
FT                                {ECO:0000305}.
FT   CONFLICT     43     43       K -> Q (in Ref. 5; AAF68412).
FT                                {ECO:0000305}.
SQ   SEQUENCE   972 AA;  111839 MW;  D933BD8C1E923685 CRC64;
     MNTLSQAIKA YNSNDYQLAL KLFEKSAEIY GRKIVEFQIT KCKEKLSAHP SVNSAHLSVN
     KEEKVNVCDS PLDIATQLLL SNVKKLVLSD SEKNTLKNKW KLLTEKKSEN AEVRAVALVP
     KDFPKDLVLA PLPDHVNDFT WYKKRKKRLG IKPEHQHVGL SIIVTTFNRP AILSITLACL
     VNQKTHYPFE VIVTDDGSQE DLSPIIRQYE NKLDIRYVRQ KDNGFQASAA RNMGLRLAKY
     DFIGLLDCDM APNPLWVHSY VAELLEDDDL TIIGPRKYID TQHIDPKDFL NNASLLESLP
     EVKTNNSVAA KGEGTVSLDW RLEQFEKTEN LRLSDSPFRF FAAGNVAFAK KWLNKSGFFD
     EEFNHWGGED VEFGYRLFRY GSFFKTIDGI MAYHQEPPGK ENETDREAGK NITLDIMREK
     VPYIYRKLLP IEDSHINRVP LVSIYIPAYN CANYIQRCVD SALNQTVVDL EVCICNDGST
     DNTLEVINKL YGNNPRVRIM SKPNGGIASA SNAAVSFAKG YYIGQLDSDD YLEPDAVELC
     LKEFLKDKTL ACVYTTNRNV NPDGSLIANG YNWPEFSREK LTTAMIAHHF RMFTIRAWHL
     TDGFNEKIEN AVDYDMFLKL SEVGKFKHLN KICYNRVLHG DNTSIKKLGI QKKNHFVVVN
     QSLNRQGITY YNYDEFDDLD ESRKYIFNKT AEYQEEIDIL KDIKIIQNKD AKIAVSIFYP
     NTLNGLVKKL NNIIEYNKNI FVIVLHVDKN HLTPDIKKEI LAFYHKHQVN ILLNNDISYY
     TSNRLIKTEA HLSNINKLSQ LNLNCEYIIF DNHDSLFVKN DSYAYMKKYD VGMNFSALTH
     DWIEKINAHP PFKKLIKTYF NDNDLKSMNV KGASQGMFMT YALAHELLTI IKEVITSCQS
     IDSVPEYNTE DIWFQFALLI LEKKTGHVFN KTSTLTYMPW ERKLQWTNEQ IESAKRGENI
     PVNKFIINSI TL
//
